Reviewers: S Vasan (Henry M Jackson Foundation) | 📘📘📘📘📘 • E Mills (McMaster University) | 📘📘📘📘📘
To read the original manuscript, click the link above.
Summary of Reviews: This preprint evaluated the effectiveness of ivermectin in shortening symptom duration or preventing hospitalization in people with mild-moderate COVID-19 symptoms. Both reviewers are in agreement that this study provides strong support for its claim that ivermectin does not seem to provide any clinically significant improvement in treatment outcomes.
Reviewer 1 (Sandhya V) | 📘📘📘📘📘
Reviewer 2 (Edward M) | 📘📘📘📘📘
RR:C19 Strength of Evidence Scale Key
📕 ◻️◻️◻️◻️ = Misleading
📙📙 ◻️◻️◻️ = Not Informative
📒📒📒 ◻️◻️ = Potentially Informative
📗📗📗📗◻️ = Reliable
📘📘📘📘📘 = Strong
To read the reviews, click the links below.